Court Rejects Bail To Two In Multi-Crore Fake Drug Scam
Nagpur: The Nagpur bench of Bombay high court last week refused bail to two accused in an alleged multi-crore spurious drug racket, holding that the investigation has prima facie revealed…
Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox
Sarvesh Singh, Director and CEO of Telangana Lifesciences and Pharma, called on industry leaders at a CII Telangana conference to embed safety by design into manufacturing culture, deploying AI, IoT,…
CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities
Amidst tariff tensions with the US, Europe has created a major opportunity for the Indian pharmaceutical industry. The CDSCO has granted approval to three Indian companies to export APIs to…
Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job
A job racket promising appointments as Panchayat Development Officers (PDOs) in the Rural Development and Panchayat Raj Department has come to light after a senior manager of a private pharmaceutical…
Puducherry drugs inspector suspended after counterfeit medicine crackdown
An order issued by Secretary to Government (Health) Choudhary Mohammed Yasin on July 23 stated that Anandakirouchenane, as Drugs Controller, was unable to stop the illegal manufacture of drugs, despite…
Researchers discover a compound that can boost ageing muscle repair
Fukuoka, Japan: Researchers led by Professor Ryuichi Tatsumi of Kyushu University’s Faculty of Agriculture have identified a molecule that could protect and enhance an important signal involved in muscle repair.…
Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks
CHENNAI: The Madras High Court on Friday dismissed a petition seeking to quash a First Information Report (FIR) registered against Puducherry-based pharmaceutical entities accused of manufacturing and distributing counterfeit medicines…
Chhattisgarh draws Rs 992.53 Cr worth pharma investment proposals in 18 months
Chhattisgarh: Riding on policy reforms that earned it the top rank among large states in NITI Aayog’s Investment Friendliness Index 2026 for Regulatory Ease and Institutional Environment, Chhattisgarh has received…
FSSAI suspends license of Punjab-based Rehaan Healthcare for breach of norms at manufacturing unit
Food regulator FSSAI on Friday said it has suspended the licence of Punjab-based Rehaan Healthcare after it found serious violations of rules at the company’s health supplements and nutraceuticals manufacturing…
Pharma companies in a flux over Trump’s 200% tariff move on generics
India’s $30-billion pharma industry is staring at a fresh challenge after US President Donald Trump announced that generic medicines imported into the US would face tariffs of 100% from Aug…
